Summit Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $87,686,000.

Profit Margin

Summit Therapeutics Inc. (NASDAQ:SMMT): Profit margin
2012 2.77M -4.23M -152.63%
2015 2.26M -17.12M -754.85%
2016 0 -24.33M
2018 35.97M -10.09M -28.05%
2019 56.41M 9.87M 17.5%
2019 811.37K -30.66M -3779.08%
2020 860K -52.69M -6127.56%
2021 1.80M -86.14M -4762.13%
2022 704.29K -74.38M -10561.06%
2023 0 -614.92M

SMMT Income Statement (2012 – 2023)

2023 2022 2021 2020 2019 2018 2017 2015 2014 2012
Revenue
Revenue
0704.29K1.80M860K811.37K56.41M35.97M02.26M2.77M
Cost of revenue
2.05M2.51M00199.49K24.91K97.66K000
Gross profit
-2.05M-1.80M1.80M860K611.87K56.38M35.88M02.26M0
Operating exp.
Research and development
59.47M51.99M85.35M53.27M41.98M51.37M41.00M23.94M15.63M4.77M
Selling and marketing
-2.05M0002.64M00000
Total operating expenses
87.68M64.28M87.99M53.19M53.92M47.68M54.13M29.44M19.28M7.43M
Operating income
-89.73M-72.08M-86.18M-53.19M-54.90M12.38M-18.25M-28.73M-19.15M-4.71M
Other income (expenses), net
-526.13M-6.69M-2.41M-14.01M18.43M-5.78M1.90M5.53M-427K6.28K
Income before tax
-615.87M-78.78M-88.60M-52.91M-36.46M6.59M-15.41M-28.69M-19.07M-4.70M
Income tax expense
-946K-4.40M-2.45M-213K-5.80M-3.27M-5.32M-4.35M-1.95M-477.37K
Net income
-614.92M-74.38M-86.14M-52.69M-30.66M9.87M-10.09M-24.33M-17.12M-4.23M
Earnings per share
Basic EPS
-0.99-0.38-0.93-0.76-0.190.11-0.16-0.41-0.43-0.02
Diluted EPS
-0.99-0.38-0.93-0.76-0.190.11-0.15-0.41-0.43-0.02
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source